US FDA declines to approve Replimune's drug for advanced skin cancer-June 2024-www.financetom.com

US FDA declines to approve Replimune's drug for advanced skin cancer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA declines to approve Replimune's drug for advanced skin cancer

Apr 10, 2026 8:44 AM

April 10 (Reuters) - The U.S. Food and Drug

Administration on Friday declined to approve Replimune's ( REPL )

drug for advanced skin cancer, the regulator said.

(Reporting by Padmanabhan Ananthan & Sruthi Narasimha Chari in

Bengaluru)

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Canadian National Railway to Invest $60 Million in Minnesota, $85 Million in Michigan

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Canadian National Railway to Invest $60 Million in Minnesota, $85 Million in Michigan

Jun 16, 2025

10:46 AM EDT, 06/16/2025 (MT Newswires) -- Canadian National Railway ( CNI ) said Monday that it plans to invest about $60 million in Minnesota and $85 million in Michigan this year, supporting track maintenance and strategic infrastructure initiatives in the two states. The investments will include a new loop track and upgrades to the company's rail yard in Two...

RTX's Pratt & Whitney Secures Engine Contract From Leidos' Dynetics

Jun 16, 2025

10:48 AM EDT, 06/16/2025 (MT Newswires) -- RTX's (RTX) Pratt & Whitney business said Monday that it got a contract from Leidos' ( LDOS ) unit Dynetics to supply TJ150 engines for integration with a small cruise missile. Work under the contract started in April and will run through Q1 2026 with an option to provide follow-on quantities, according to...

Boralex, Northland Power, Brookfield Renewable Partners to Benefit from Ontario's 'Energy for Generations' Plan, National Bank Says

Jun 16, 2025

10:51 AM EDT, 06/16/2025 (MT Newswires) -- National Bank of Canada has an Outperform rating on each of Boralex ( BRLXF ) (Target C$42), Northland (Target $30) and Brookfield Renewable Partners (Target US$30) as it published a read through for companies in its coverage after Ontario unveiled its 'Energy For Generations' plan. For Boralex ( BRLXF ) and Northland Power...